A nurse is providing care for a client who experienced a myocardial infarction prior to a cardiac arrest. Which of the following laboratory tests will identify early injury to the cardiac muscle?

A. Comply with compression therapy:

Compression therapy typically refers to the use of compression garments or devices to improve circulation and reduce swelling in the extremities, particularly in conditions such as venous insufficiency or deep vein thrombosis.

While compression therapy may be beneficial for certain circulatory disorders, it is not a standard treatment for cardiac tamponade.

Cardiac tamponade is a medical emergency characterized by the accumulation of fluid in the pericardial sac, leading to increased pressure on the heart and impaired cardiac function.

Treatment for cardiac tamponade involves prompt recognition and intervention to relieve the pressure on the heart, such as pericardiocentesis or surgical drainage of the pericardial effusion.

B. Monitor wounds on lower extremities:

Monitoring wounds on the lower extremities is essential for assessing healing, preventing complications such as infection, and promoting overall wound care.

However, monitoring wounds on the lower extremities is not directly related to the management or monitoring of cardiac tamponade.

In cardiac tamponade, the focus of monitoring is on assessing signs and symptoms of cardiac compromise, such as hypotension, tachycardia, dyspnea, and pulsus paradoxus, rather than wound care.

C. Take antiplatelet medications as ordered:

Antiplatelet medications, such as aspirin or clopidogrel, are commonly prescribed to prevent platelet aggregation and reduce the risk of thrombotic events, particularly in patients with cardiovascular disease or a history of myocardial infarction or stroke.

While antiplatelet medications may be part of the long-term management of certain cardiac conditions, they are not specific to the treatment or monitoring of cardiac tamponade.

The primary treatment for cardiac tamponade involves interventions to relieve the pressure on the heart and restore cardiac function, such as pericardiocentesis or surgical drainage of the pericardial effusion.

D. Monitor for gradual onset of symptoms:

Phase II of cardiac tamponade is characterized by a gradual onset of symptoms as the pressure within the pericardial sac increases, leading to impaired cardiac filling and decreased cardiac output.

Symptoms may include dyspnea, fatigue, orthopnea, tachycardia, and chest discomfort, which may develop gradually over time.

Early recognition of symptoms is crucial for prompt diagnosis and intervention to prevent further deterioration and improve outcomes in patients with cardiac tamponade.

A. Comply with compression therapy: Compression therapy is commonly used in the management of peripheral vascular disease (PVD), not valvular heart disease. It involves applying external pressure to the limbs to improve circulation and reduce edema. While this intervention may be relevant for a client with PVD, it is not specific to valvular heart disease.

B. Monitor wounds on lower extremities: Monitoring wounds on lower extremities is important for clients with peripheral vascular disease (PVD) to assess for signs of poor wound healing, infection, or tissue ischemia. However, it is not directly related to valvular heart disease. Therefore, while wound monitoring may be appropriate for this client, it is not specific to valvular heart disease education.

C. Take antiplatelet medications as ordered: Antiplatelet medications, such as aspirin or clopidogrel, are commonly prescribed for clients with peripheral vascular disease (PVD) to reduce the risk of thrombotic events and improve blood flow. However, they are not typically indicated as a primary treatment for valvular heart disease. While some clients with valvular heart disease may have comorbidities that warrant antiplatelet therapy, it is not specific to valvular heart disease education.

D. Valvular heart disease involves dysfunction of one or more heart valves, leading to impaired blood flow within the heart. The nurse should educate the client on monitoring for the gradual onset of symptoms related to valvular heart disease. These symptoms may include dyspnea (shortness of breath), fatigue, palpitations, chest discomfort, and edema. Monitoring for these symptoms allows for early detection of disease progression or exacerbation, prompting timely intervention and management.